Small Hypervascular Hepatocellular Carcinoma: Limited Value of Portal and Delayed Phases on Dynamic Magnetic Resonance Imaging

References

• Oi H, Murakami T, Kim T, Matsushita M, Kishimoto H, Nakamura H. Dynamic MR imaging and early phase helical CT for detecting small intrahepatic metastases of hepatocellular carcinoma. Am J Roentgenol 1996; 166: 369–74
   Google Scholar
• Yamashita Y, Mitsuzaki K, Yi T, Ogata I, Nishiharu T, Urata J, et al. Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver. Radiology 1996; 200: 79–84
   PubMedGoogle Scholar
• Imaging of malignant focal liver lesions. In: Schneider G, Grazioli L, Saini S, MRI of the liver. 2nd edition. Milan: Springer; 2006. p. 187–236.
   Google Scholar
• Yu JS, Kim KW, Jeong MG, Lee JT, Yoo HS. Nontumorous hepatic arterial-portal venous shunts: MR imaging findings. Radiology 2000; 217: 750–6
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona 2000 EASL conference. J Hepatol 2001; 35: 421–30
   PubMed Web of Science ®Google Scholar
• Earls JP, Rofsky NM, DeCorato DR, Krinsky GA, Weinreb JC. Hepatic arterial-phase dynamic gadolinium-enhanced MR imaging: optimization with a test examination and a power injector. Radiology 1997; 202: 268–73
   Google Scholar
• Yu JS, Park JG, Jeong EK, Park MS, Kim KW. Hepatic MRI using the double-echo chemical shift phase-selective gradient-echo technique. Am J Roentgenol 2007; 188: W49–56
   Google Scholar
• Marrero JA, Hussain HK, Nghiem HV, Umar R, Fontana RJ, Lok AS. Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass. Liver Transpl 2005; 11: 281–9
   PubMed Web of Science ®Google Scholar
• Murakami T, Kim T, Nakamura M. Hepatitis, cirrhosis and hepatoma. J Magn Reson Imaging 1998; 8: 346–58
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005;42:1208–36.
   PubMed Web of Science ®Google Scholar
• Fan ZH, Chen MH, Dai Y, Wang YB, Yan K, Wu W, et al. Evaluation of primary malignancies of the liver using contrast-enhanced sonography: correlation with pathology. Am J Roentgenol 2006; 186: 1512–9
   PubMed Web of Science ®Google Scholar
• Rettenbacher T. Focal liver lesions: role of contrast-enhanced ultrasound. Eur J Radiol 2007; 64: 173–82
   PubMed Web of Science ®Google Scholar
• Iannaccone R, Laghi A, Catalano C, Rossi P, Mangiapane F, Murakami T, et al. Hepatocellular carcinoma: role of unenhanced and delayed phase multi-detector row helical CT in patients with cirrhosis. Radiology 2005; 234: 460–7
   PubMedGoogle Scholar
• Hwang GJ, Kim MJ, Yoo HS, Lee JT. Nodular hepatocellular carcinomas: detection with arterial-, portal-, and delayed-phase images at spiral CT. Radiology 1997; 202: 383–8
   PubMed Web of Science ®Google Scholar
• Lim JH, Choi D, Kim SH, Lee SJ, Lee WJ, Lim HK, et al. Detection of hepatocellular carcinoma: value of adding delayed phase imaging to dual-phase helical CT. Am J Roentgenol 2002; 179: 67–73
   PubMed Web of Science ®Google Scholar
• Araki T, Itai Y, Furui S, Tasaka A. Dynamic CT densitometry of hepatic tumors. Am J Roentgenol 1980; 135: 1037–43
   Google Scholar
• Krinsky GA, Lee VS, Theise ND, Weinreb JC, Rofsky NM, Diflo T, et al. Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation. Radiology 2001; 219: 445–54
   PubMedGoogle Scholar
• Weinmann HJ, Brasch RC, Press WR, Wesbey GE. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. Am J Roentgenol 1984; 142: 625–30
   Google Scholar
• Yu JS, Kim MJ. Hepatocellular carcinoma: contrast-enhanced MRI. Abdom Imaging 2002; 27: 157–67
   Google Scholar
• Grazioli L, Olivetti L, Fugazzola C, Benetti A, Stanga C, Dettori E, et al. The capsule in hepatocellular carcinoma: correlation between dynamic MR imaging and pathology. Eur Radiol 1999; 9: 62–7
   PubMedGoogle Scholar
• Lim JH, Choi D, Park CK, Lee WJ, Lim HK. Encapsulated hepatocellular carcinoma: CT-pathologic correlations. Eur Radiol 2006; 16: 2326–33
   Google Scholar
• Terminology of nodular hepatocellular lesions. International Working Party. Hepatology 1995;22:983–93.
   Google Scholar
• Ito K, Fujita T, Shimizu A, Koike S, Sasaki K, Matsunaga N, et al. Multiarterial phase dynamic MRI of small early enhancing hepatic lesions in cirrhosis or chronic hepatitis: differentiating between hypervascular hepatocellular carcinomas and pseudolesions. Am J Roentgenol 2004; 183: 699–705
   PubMedGoogle Scholar
• Ueda K, Matsui O, Kawamori Y, Kadoya M, Yoshikawa J, Gabata T, et al. Differentiation of hypervascular hepatic pseudolesions from hepatocellular carcinoma: value of single-level dynamic CT during hepatic arteriography. J Comput Assist Tomogr 1998; 22: 703–8
   Google Scholar
• Hussain HK, Syed I, Nghiem HV, Johnson TD, Carlos RC, Weadock WJ, et al. T2-weighted MR imaging in the assessment of cirrhotic liver. Radiology 2004; 230: 637–44
   Google Scholar
• Ebara M, Ohto M, Watanabe Y, Kimura K, Saisho H, Tsuchiya Y, et al. Diagnosis of small HCC: correlation of MR imaging and tumor histologic studies. Radiology 1986; 159: 371–7
   PubMedGoogle Scholar